Ardelyx, Inc.ARDXNASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 94% recommend buying.

Consensus Rating

Buy

16 analysts·Moderate coverage

94%

Rating Distribution

Strong Buy

00%

Buy

1594%

Hold

16%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 102% higher.

Bear Case

$12.00

+56%

Consensus

$15.50

+102%

Bull Case

$19.00

+147%

Price Range16 analysts

Low

Consensus

High

$12.00

$19.00

Current Target

Current Price

$7.69

Upside to Target

$7.81

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$0.17(8 analysts)

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+33.06%

EPS+337.17%

FY2028

Rev+27.75%

EPS+66.65%

FY2029

Rev+20.90%

EPS+34.54%

Earnings Surprises

Beat rate:67%(8/12 quarters)

Avg surprise:+532.9%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Jan 27, 2026Jefferies

Ardelyx price target raised to $15 from $8 at Jefferies

Target:$15.00

+92.3%from $7.80

Jan 9, 2026BTIG

Ardelyx price target raised to $17 from $14 at BTIG

Target:$17.00

+142.9%from $7.00

Jan 8, 2026Piper Sandler

Ardelyx upgraded to Overweight from Neutral at Piper Sandler

Target:$16.00

+128.6%from $7.00

Jan 8, 2026Raymond James

Ardelyx price target raised to $19 from $16 at Raymond James

Target:$19.00

+171.6%from $7.00

Nov 4, 2025Piper Sandler

Ardelyx price target raised to $10 from $9 at Piper Sandler

Target:$10.00

+70.6%from $5.86

Aug 5, 2025Wedbush

Ardelyx price target raised to $14 from $13 at Wedbush

Target:$14.00

+172.9%from $5.13

Aug 5, 2025UBS

Ardelyx price target raised to $12 from $11 at Raymond James

Target:$12.00

+133.9%from $5.13

Mar 4, 2025BTIG

Ardelyx initiated with a Buy at BTIG

Target:$14.00

+158.8%from $5.41

Jan 2, 2025Jefferies

Ardelyx price target lowered to $8 from $11 at Jefferies

Target:$8.00

+56.3%from $5.12

Aug 5, 2024H.C. Wainwright

Ardelyx price target raised to $11 from $10 at H.C. Wainwright

Target:$11.00

+81.8%from $6.05

Jul 5, 2024H.C. Wainwright

Ardelyx, Inc (ARDX) PT Lowered to $10 at H.C. Wainwright

Target:$10.00

+89.0%from $5.29

May 24, 2024Raymond James

Ardelyx Chief Commercial Officer exit not positive, says Piper Sandler

Target:$15.00

+108.3%from $7.20

Dec 18, 2023Raymond James

Patient Demand Drives Ardelyx's Constipation Drug Success Amid IBS-C Treatment Gap, Says Analyst

Target:$12.00

+90.3%from $6.30

Dec 30, 2022Citigroup

Citigroup Maintains Buy on Ardelyx, Raises Price Target to $7

Target:$7.00

+145.6%from $2.85

Dec 29, 2022Wedbush

Ardelyx approval for tenapanor 'still far from a slam dunk,' says Wedbush

Target:$2.00

-14.3%from $2.33

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance